Veradigm Inc.

NASDAQ MDRX

Download Data

Veradigm Inc. Price to Sales Ratio (P/S) on June 03, 2024: 1.23

Veradigm Inc. Price to Sales Ratio (P/S) is 1.23 on June 03, 2024, a -19.51% change year over year. The price to sales ratio compares the market price per share of a company's stock to its sales revenue per share. It is calculated by dividing the market capitalization by the revenue, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's sales revenue. A higher ratio suggests that investors are willing to pay a higher price for each unit of sales revenue, indicating positive market sentiment and expectations for future revenue growth.
  • Veradigm Inc. 52-week high Price to Sales Ratio (P/S) is 1.83 on October 09, 2023, which is 48.13% above the current Price to Sales Ratio (P/S).
  • Veradigm Inc. 52-week low Price to Sales Ratio (P/S) is 0.89 on February 28, 2024, which is -27.99% below the current Price to Sales Ratio (P/S).
  • Veradigm Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.50.
NASDAQ: MDRX

Veradigm Inc.

CEO Mr. Richard J. Poulton
IPO Date July 26, 1999
Location United States
Headquarters 222 Merchandise Mart Plaza, Chicago, IL, United States, 60654
Employees 8,000
Sector Healthcare
Industry Health information services
Description

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Similar companies

FORA

Forian Inc

NA

NA

HQY

HealthEquity Inc

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email